Pyk2 in the amygdala modulates chronic stress sequelae via PSD-95-related microstructural changes
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Publishing Group
Abstract
Major depressive disorder (MDD) is a common disorder with a variety of symptoms including mood alterations,
anhedonia, sleep and appetite disorders, and cognitive disturbances. Stressful life events are among the strongest risk
factors for developing MDD. At the cellular level, chronic stress results in the modification of dendritic spine
morphology and density. Here, we study the role of Pyk2 in the development of depressive-like symptoms induced by
a model of chronic unpredictable mild stress (CUMS). Pyk2 is a non-receptor calcium-dependent protein-tyrosine
kinase highly expressed in the forebrain principal neurons and involved in spine structure and density regulation. We
show that Pyk2 knockout mice are less affected to anxiety-like and anhedonia-like phenotypes induced by the CUMS
paradigm. Using region-specific knockout, we demonstrate that this phenotype is fully recapitulated by selective Pyk2
inactivation in the amygdala. We also show that in the absence of Pyk2 the spine alterations, PSD-95 clustering, and
NMDA receptors changes induced by the CUMS paradigm are prevented. Our results reveal a possible role for Pyk2 in
the response to stress and in synaptic markers expression and spine density regulation in the amygdala. We suggest
that Pyk2 contributes to stress-induced responses through micro-structural changes and that its deficit may contribute
to the resilience to chronic stress
Description
Keywords
Bibliographic citation
Montalban, E., Al-Massadi, O., Sancho-Balsells, A., Brito, V., Pins, B. d., Alberch, J., Ginés, S., Girault, J.A. and Giralt,A. (2019). Pyk2 in the amygdala modulates chronic stress sequelae via PSD-95-related micro-structural changes. Transl. Psychiatry 9, 3. doi: 10.1038/s41398-018-0352-y
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1038/s41398-018-0352-ySponsors
A.G. is a Ramón y Cajal fellow (RYC-2016-19466). This work was supported by the NARSAD foundation (young investigator grant 2016 (Ref. 24803) to A.G.) and Ministerio de Ciencia e Innovació n (SAF2015-67474-R; MINECO/FEDER to S.G.). J.-A.G. lab was supported in part by Inserm, the Université Pierre et Marie Curie (UPMC, Sorbonne Université), the Fondation pour la Recherche Médicale, and the Bio-Psy (Biology for Psychiatry) laboratory of excellence. O.A.-M. was funded by the ISCIII/SERGAS thought a research contract “Sara Borrell” (CD14/ 00091). JA lab was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (SAF-2014-57160R, SAF-2017-88076-R), Fundació Marató TV3 to J.A. and Instituto Carlos III: Centro de Investigación Biomédica en Red sobre enfermedades neurodegenerativas (CIBERNED), and RETICS RD12/ 0019/0002 to J.A.)
Rights
© The Author(s) 2019. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/



